pharma · Opioid Use Disorder · Opioid Dependence
Indivior Pty
Indivior Pty Ltd
Indivior Pty clinical programs — 13 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- ., Richmond, VA, US
- Employees
- 967
- Programs
- 39
- Drugs
- 19
- Patents
- 34
Indivior Pty projects
13 ClinicalTrials.gov programs sponsored by Indivior Pty.
Indivior Pty has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
2.0mg Buprenorphine/0.5mg Naloxone
Indivior Pty Ltd
Hepatic Failure
1 trial -
Buprenorphine (Subutex)
Indivior Pty Ltd
Opioid Dependency
1 trial -
Buprenorphine + naloxone (Suboxone)
Indivior Pty Ltd
Opiate Dependence
1 trial -
Buprenorphine Extended-Release Injection
Indivior Pty Ltd
Opioid Use Disorder
1 trial -
INDV-6000-406
Indivior Pty Ltd
Opioid Use Disorder
1 trial -
P04843
Indivior Pty Ltd
Opiate Dependence
1 trial -
PERSERIS
Indivior Pty Ltd
Schizophrenia
1 trial -
Sublocade
Indivior Pty Ltd
Opioid Use Disorder, Severe
1 trial -
Suboxone Sublingual Film
Indivior Pty Ltd
Opioid Dependence
1 trial -
TM buprenorphine
Indivior Pty Ltd
Opioid-use Disorder
1 trial -
Transmucosal Buprenorphine
Indivior Pty Ltd
Moderate to Severe Opioid-use Disorder
1 trial -
buprenorphine
Indivior Pty Ltd
Hepatitis C, Chronic
1 trial -
buprenorphine
Indivior Pty Ltd
Opiate-related Disorders
1 trial
Frequently asked questions
How many clinical projects does Indivior Pty have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.